Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 37Prostatic Neoplasms 19Multiple Myeloma 17Neoplasm Metastasis 14Osteoporosis 8Neuroblastoma 6Pain 5Osteosarcoma 5Neoplasms, Plasma Cell 5Carcinoma, Non-Small-Cell Lung 5Neoplasms 4Lung Neoplasms 4Carcinoma, Renal Cell 4Sarcoma, Ewing 3Bone Diseases, Metabolic 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Sarcoma 2Rhabdomyosarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Osteonecrosis 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Lymphoma 2Kidney Neoplasms 2Humoral Hypercalcemia Of Malignancy 2Giant Cell Tumor of Bone 2Carcinoma, Hepatocellular 2Breast Neoplasms, Male 2Adenocarcinoma 2

Interventions

trisacryl gelatin microspheres 1Zoledronic Acid 1Radiosurgery 1Mitomycin 1Ethiodized Oil 1Chemoembolization, Therapeutic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lung Metastases × Zoledronic Acid × Clear all
NCT03932071 2019-05-06

Zoledronic Acid in Decrease the Lung Metastatic Rate of Osteosarcoma

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 4 Unknown
150 enrolled

Lung Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡